| Trial Identifier: | 3475-365 |
| Sponsor: | MSD |
| Start Date: | November 2016 |
| Primary Completion Date: | October 2027 |
| Study Completion Date: | October 2027 |
| Condition: | Prostate Cancer |
For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.
| Language | Description |
| Protocol Plain Language Summary - English |
| Country | Location |
|---|---|
| Australia | North Ryde, Australia |
| Canada, Quebec | Kirkland, Quebec, Canada, H9H 4M7 |
| Denmark | Glostrup, Denmark |
| Finland | Espoo, Finland |
| France | Paris, France |
| Germany | Haar, Germany |
| Ireland | Dublin, Ireland |
| Italy | Rome, Italy |
| Mexico | Mexico City, Mexico |
| Netherlands | Haarlem, Netherlands |
| New Zealand | Auckland, New Zealand |
| Poland | Warsaw, Poland |
| Spain | Madrid, Spain |
| Sweden | Stockholm, Sweden |
| Taiwan | Taipei, Taiwan |
| Turkey | Istanbul, Turkey |
| United Kingdom | Hoddesdon, United Kingdom |
| United States, CA | Los Angeles, CA, United States, 90404 |
| United States, CO | Aurora, CO, United States, 80045 |
| United States, IL | Chicago, IL, United States, 60607 |
| United States, MD | Baltimore, MD, United States, 21201 |
| United States, NC | Cary, NC, United States, 27518 |
| United States, OH | Cleveland, OH, United States, 44195 |
| United States, OR | Portland, OR, United States, 97239 |
| United States, PA | Pittsburgh, PA, United States, 15232 |
| United States, SC | Charleston, SC, United States, 29401 |
| United States, WA | Seattle, WA, United States, 98109 |
Powered by
Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.
Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company